Although previous studies have shown that GLP1-RAs tend to induce less weight loss in patients with than without T2D [29, 30, 32, 33], no statistically significant difference was observed in this study (Supplement)
Metabolic therapies that lower fatty acid intake and oxidation, enhance glucose oxidation, and increase ketone and branched-chain amino acid oxidation offer hope for improving the prognosis of heart failure patients
Does exactly what it says
Understanding the specific cellular pathways and molecular targets could guide future drug development efforts
It is not intended for human consumption, diagnostic, therapeutic, or veterinary use.
Compounded drugs are mixed in specialized pharmacies using the same active ingredient found in FDA-approved medicines